Simplicis a provider of modern sample and inventory management software for life sciences, today announced that Flare Therapeutics has selected Simplicis Ledger™ as its primary compound and inventory management platform. The partnership marks a strategic shift for Flare Tx, moving away from fragile, person-dependent workflows toward a resilient, automated foundation for drug discovery.
As biotech teams remain lean, many organizations face “operational fragility”, where critical scientific data relies on a single individual or a web of manual workarounds. Flare Therapeutics recognized this bottleneck and chose Ledger™ to bridge the gap between physical inventory and digital automation.
“We reached a point where our system required more human babysitting and workarounds than I could reliably provide without help,” said Caitlin, Compound Management Lead at Flare Therapeutics. “As the primary compound manager in the company, I needed infrastructure we could actually trust. Ledger™ gives us that, allowing us to scale without increasing headcount or overhead.”
Breaking the Cycle of “Offline” Data Management
Prior to this implementation, Flare Tx’s workflows, including assay-ready plate production and acoustic dispensing required significant manual oversight and custom IT workarounds. These “offline” processes created operational risks and hindered cross- training.
By implementing Ledger™ and Ledger™ Acoustic, Flare Tx has achieved:
- End-to-End Transparency: Real-time alignment between inventory state and assay execution.
- Automation-Ready Workflows: Seamless integration with acoustic dispensing platforms, removing the need for manual file handling.
- Operational Continuity: A unified system that allows for predictable workflow management and easier team-wide adoption.
“Flare Tx’s move reflects a broader biotech trend: the shift from brittle, workaround- driven systems to ‘Scientific Infrastructure’ that supports velocity,” said James Craven, Chief Commercial Officer at Simplicis. “Ledger™ was designed to remove the hidden friction between inventory, automation, and people.”
For more information on how Simplicis is modernizing R&D infrastructure, visit www.simplicis.com
#Flare #Therapeutics #Partners #Simplicis #Eliminate #SinglePointofFailure #Risks #Compound #Management